Skip to Main Content

The (POGO) Blog

July 4, 2017

By Elizabeth "Liz" Hempowicz

FOIA Turns 51: What Is It and Why Does It Matter?



U.S. flag and fireworks On the 51st birthday of the Freedom of Information Act, POGO explains what FOIA is and why it continues to matter.

Continue Reading FOIA Turns 51: What Is It and Why Does It Matter?

Topics: Open Government

June 8, 2017

By Laura Peterson

More Trump Appointees Get Waived Past Ethics Pledge



White House Ethics Waiver The Office of Government Ethics posted waivers to the ethics pledge for 10 Trump appointees after demanding them from federal agencies.

Continue Reading More Trump Appointees Get Waived Past Ethics Pledge

Topics: Government Accountability, Open Government

April 21, 2017

By Elizabeth "Liz" Hempowicz

For Now, Secrecy Trumps Transparency at the White House



Photo of the White House Gate Unfortunately, the Trump Administration has decided they will not disclose the names of visitors to the White House, a giant step backwards from the previous administration.

Continue Reading For Now, Secrecy Trumps Transparency at the White House

Topics: Open Government

March 28, 2017

By Ari Goldberg

POGO's 2017 Baker’s Dozen Wishlist for Congress



Aerial U.S. Capitol Building The Project On Government Oversight (POGO) has unveiled its biennial list of 13 policy areas ripe for Congressional action. It includes recommendations for legislative fixes to make the federal government more transparent, accountable, and ethical.

Continue Reading POGO's 2017 Baker’s Dozen Wishlist for Congress

Topics: Government Accountability, Open Government, Whistleblower Protections, Energy and Natural Resources, National Security, Public Health and Science, Contract Oversight

March 3, 2017

By David S. Hilzenrath

Trump’s Dangerous Prescription for the FDA



President Trump addressing a joint session of Congress, with VP Mike Pence and Rep. Paul Ryan seated behind him, clapping. President Donald Trump called the FDA drug approval process slow and burdensome, but the evidence he cited could point to the opposite conclusion. Slashing regulatory restraints as he proposed could pose medical and financial hazards.

Continue Reading Trump’s Dangerous Prescription for the FDA

Topics: Government Accountability, Open Government, Public Health and Science

Items 1 - 5 of 75  12345678910Next

Browse POGOBlog by Topic

POGO on Facebook